Incorporation of Genetic Expression of Airway Epithelium With CT Screening for Lung Cancer
Sponsor: Weill Medical College of Cornell University
Terminated
Lack of funding
Other terminated trials from Weill Medical College of Cornell University
- Epilepsy · Apr 2025
- Anxiety Disorders · Phase NA · Nov 2024
- Myeloproliferative Neoplasm · Phase PHASE2 · Jul 2024
- Infertility, Male · Phase PHASE2 · May 2024
- Anxiety · Apr 2024
See all terminations from Weill Medical College of Cornell University
A observational or N/A phase clinical study on COPD and Chronic Obstructive Pulmonary Disease, this trial is terminated or withdrawn. The trial is conducted by Weill Medical College of Cornell University and has accumulated 13 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
-
Jan 2021 — Dec 2021 [monthly]
Terminated
-
Nov 2020 — Jan 2021 [monthly]
Terminated
▶ Show 8 earlier versions
-
Aug 2020 — Nov 2020 [monthly]
Terminated
Status: Active Not Recruiting → Terminated
-
May 2019 — Aug 2020 [monthly]
Active Not Recruiting
-
Jun 2018 — May 2019 [monthly]
Active Not Recruiting
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — May 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Jun 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Jun 2017 [monthly]
Active Not Recruiting NA
First recorded
Jun 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Weill Medical College of Cornell University
For direct contact, visit the study record on ClinicalTrials.gov .